跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 48,452 条关于
“BridgeBio Pharma Inc”
全部
48,452
临床试验
15,138
药物
2,633
机构
7,129
资讯
23,552
去年
BridgeBio Pharma Receives Optimistic Buy Recommendation Amid Promising Drug Developments
去年
FDA Approves BridgeBio's Acoramidis (ATTRUBY) for Transthyretin Amyloid Cardiomyopathy
去年
BridgeBio's Attruby Receives FDA Approval for ATTR-CM Treatment
去年
BridgeBio's Attruby Sees Strong Early Demand; Phase 3 Trials Fully Enrolled
去年
FDA Approves Attruby (Acoramidis) for ATTR-CM, Showing Near-Complete TTR Stabilization
3年前
Viking Therapeutics, Biomea Fusion, and Ardelyx Inc. Lead Biotech Stock Gains with Promising Clinical Results
去年
Infigratinib Shows Promise as Oral Treatment for Achondroplasia in Children
去年
KRAS Inhibitor Market to Reach $186.4 Million by 2033, Driven by Targeted Cancer Therapies
去年
BridgeBio's Attruby Approved for ATTR-CM, Cassava's Simufilam Fails in Alzheimer's Trial
去年
BridgeBio Reports Positive Pipeline Progress and Q3 2024 Financial Results
第 1 页,共 2356 页
上一页
下一页